Biomerica Inc (BMRA) - Total Liabilities
Based on the latest financial reports, Biomerica Inc (BMRA) has total liabilities worth $1.56 Million USD as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Biomerica Inc to track the company's year-over-year net asset growth rate.
Biomerica Inc - Total Liabilities Trend (1986–2025)
This chart illustrates how Biomerica Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Biomerica Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Biomerica Inc Competitors by Total Liabilities
The table below lists competitors of Biomerica Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sentral Mitra Informatika Tbk PT
JK:LUCK
|
Indonesia | Rp22.81 Billion |
|
Jain Irrigation Systems Limited
NSE:JISLDVREQS
|
India | Rs61.58 Billion |
|
Picton Property Income Ltd
LSE:PCTN
|
UK | GBX229.33 Million |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
USA | $7.14 Million |
|
PLENUM AG NA O.N.
F:PLEK
|
Germany | €8.32 Million |
|
Sentage Holdings Inc
NASDAQ:SNTG
|
USA | $2.00 Million |
|
Alpha Compute Corp
NASDAQ:ALP
|
USA | $21.70 Million |
|
Blue Coast Hotels Limited
NSE:BLUECOAST
|
India | Rs285.76 Million |
Liability Composition Analysis (1986–2025)
This chart breaks down Biomerica Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Biomerica Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biomerica Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biomerica Inc (1986–2025)
The table below shows the annual total liabilities of Biomerica Inc from 1986 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-05-31 | $1.84 Million | -30.90% |
| 2024-05-31 | $2.66 Million | -2.45% |
| 2023-05-31 | $2.73 Million | -10.48% |
| 2022-05-31 | $3.05 Million | +17.66% |
| 2021-05-31 | $2.59 Million | -14.93% |
| 2020-05-31 | $3.05 Million | +140.97% |
| 2019-05-31 | $1.26 Million | +40.99% |
| 2018-05-31 | $896.81K | +69.57% |
| 2017-05-31 | $528.87K | +4.51% |
| 2016-05-31 | $506.03K | -3.42% |
| 2015-05-31 | $523.93K | -5.74% |
| 2014-05-31 | $555.84K | -0.72% |
| 2013-05-31 | $559.89K | -5.47% |
| 2012-05-31 | $592.29K | -5.24% |
| 2011-05-31 | $625.01K | -34.37% |
| 2010-05-31 | $952.30K | +18.43% |
| 2009-05-31 | $804.09K | -34.29% |
| 2008-05-31 | $1.22 Million | -16.86% |
| 2007-05-31 | $1.47 Million | +7.87% |
| 2006-05-31 | $1.36 Million | -39.56% |
| 2005-05-31 | $2.26 Million | +9.90% |
| 2004-05-31 | $2.05 Million | -10.76% |
| 2003-05-31 | $2.30 Million | +16.21% |
| 2002-05-31 | $1.98 Million | +8.41% |
| 2001-05-31 | $1.83 Million | -0.01% |
| 2000-05-31 | $1.83 Million | +14.22% |
| 1999-05-31 | $1.60 Million | +23.08% |
| 1998-05-31 | $1.30 Million | -13.33% |
| 1997-05-31 | $1.50 Million | -25.00% |
| 1996-05-31 | $2.00 Million | -23.08% |
| 1995-05-31 | $2.60 Million | -13.33% |
| 1994-05-31 | $3.00 Million | -14.29% |
| 1993-05-31 | $3.50 Million | -14.63% |
| 1992-05-31 | $4.10 Million | -14.58% |
| 1991-05-31 | $4.80 Million | +9.09% |
| 1990-05-31 | $4.40 Million | +780.00% |
| 1989-05-31 | $500.00K | -28.57% |
| 1988-05-31 | $700.00K | -58.82% |
| 1987-05-31 | $1.70 Million | +21.43% |
| 1986-05-31 | $1.40 Million | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more